Seven Big Pharma Join Critical Path To New Parkinson's Treatments
This article was originally published in Scrip
Executive Summary
Seven big pharma companies have joined forces with the medical charity Parkinson's UK and the Critical Path Institute (C-Path) to share data, expertise and resources to boost R&D into new treatments for Parkinson's disease (PD).